Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

China flag China · Delayed Price · Currency is CNY
45.38
+1.94 (4.47%)
Jul 31, 2026, 3:04 PM CST
Market Cap11.98B +3.8%
Revenue (ttm)1.63B +19.8%
Net Income157.25M +58.5%
EPS0.59 +56.1%
Shares Out 263.99M
PE Ratio77.00
Forward PE41.25
Dividend0.02 (0.03%)
Ex-Dividend DateJul 6, 2026
Volume9,425,591
Open43.60
Previous Close43.44
Day's Range43.11 - 46.23
52-Week Range36.50 - 90.68
Beta-0.28
Analystsn/a
Price Targetn/a
Earnings DateAug 25, 2026

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liver disease; and FibroView data management software. It provides digital health management services; compound turtle shell softening liver tablets; and ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 946
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300049
Full Company Profile

Financial Performance

In 2025, SHE:300049's revenue was 1.60 billion, an increase of 18.26% compared to the previous year's 1.35 billion. Earnings were 154.09 million, an increase of 36.02%.

Financial Statements